LOADING
Comparing AbbVie Inc (ABBV) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | T |
|---|---|---|
| Price | $219.68 | $27.72 |
| Change Today | -2.52% | +1.20% |
| Market Cap | $388.4B | $196.5B |
| P/E Ratio | 92.7 | 9.1 |
| Forward P/E | 15.1 | 11.9 |
| PEG Ratio | 0.52 | 1.54 |
| EPS | $2.37 | $3.04 |
| Revenue Growth (YoY) | 10.0% | 3.6% |
| Profit Margin | 6.9% | 17.5% |
| Return on Equity | 62.3% | 18.8% |
| Dividend Yield | 2.95% | 4.05% |
| Beta | 0.33 | 0.58 |
| 52-Week High | $241.12 | $29.30 |
| 52-Week Low | $159.05 | $22.95 |
| Volume | 5.7M | 28.1M |
AbbVie Inc is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AT&T Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.